Abstract
Pereira et al.1 report in this issue of the Journal on the high morbidity associated with the transplantation of organs from 13 cadaver donors who were positive for antibodies against the hepatitis C virus (HCV). This study of 716 donors from the New England Organ Bank shows what valuable information may be obtained by storing relevant serum samples from donors and recipients of transplants at a time when we are still learning about viruses and other microbial agents transmitted by body fluids, tissues, and organs, and the diseases they may cause.2 Non-A, non-B hepatitis developed in 48 percent of the . . .